Compound Name
(alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
|---|
| Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
|---|
BDBM10015
 | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | - Bile salt export pump
- Canalicular multispecific organic anion transporter 1
- Canalicular multispecific organic anion transporter 2
- Cytochrome P450 19A1
- Multidrug resistance-associated protein 4
- Uridine-5'-diphosphoglucuronosyltransferase 1A4
| - 2-[3-(1-cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
- 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile
- ANASTROZOLE
- CHEMBL1399
- NSC719344
- arimidex
|
BDBM103467
 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 3A
- DNA-dependent protein kinase
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
- Serine-protein kinase ATM
- Serine/threonine-protein kinase ATR
- mTOR/FKBP12A/FKBP12B
| |
BDBM104692
 | 12 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
- Orexin receptor type 2 (OX2)
| |
BDBM107664
 | 0 | 15 | 0 | 1 | 0 | 0 | 0 | 0 | - 11-beta-hydroxysteroid dehydrogenase
- 11-beta-hydroxysteroid dehydrogenase 1
- 11-beta-hydroxysteroid dehydrogenase 2
- 3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 3A
- Estradiol 17-beta-dehydrogenase 1
- Melanin-concentrating hormone receptor 2/HERG
- Nuclear receptor subfamily 1 group I member 2
| |
BDBM10851
 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - Heat Shock Protein 90 (Hsp90)
- cAMP-activated global transcriptional regulator CRP
- cyclic AMP receptor protein
| - (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-1,3,5,2-furo[3,2-d][1,3,2]dioxaphosphinin-2-one
- (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide
- ADENOSINE-3 ,5 -CYCLIC-MONOPHOSPHATE
- Cyclic adenosine monophosphate
- cAMP
- cid_23902375
|
BDBM109086
 | 0 | 15 | 1 | 0 | 0 | 0 | 0 | 0 | - Glutamate dehydrogenase 2, mitochondrial
- Glutaminase kidney isoform, mitochondrial
| - US10793535, Cmpd ID 727
- US8604016, 670
- US9938267, Cmpd ID 670
|
BDBM118635
 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| - US8653263, 288
- US9586962, Example 288
|
BDBM127726
 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | - High affinity nerve growth factor receptor
- JAK2 (aa 808-1132)
- Tyrosine-protein kinase JAK2
| - US10251889, Example 100
- US10758542, Example 100
- US8791123, 99
- US9782415, Example 99
- US9796724, Example 100
|
BDBM13246
 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | - Cyclin-dependent kinase 2
- Epidermal growth factor receptor
- Fibroblast growth factor receptor
- Focal adhesion kinase 1
- MAP kinase p38
- Proto-oncogene tyrosine-protein kinase Src
- Receptor tyrosine-protein kinase erbB-2
- Tyrosine-protein kinase Fyn
- Tyrosine-protein kinase HCK
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase Lck
- Vascular endothelial growth factor receptor 2
| - 5-N-(2-chloro-6-methylphenyl)-2-N-cyclopropane-1,3-thiazole-2,5-diamido
- BMS-354825 2-Carboxamido-4-hydrido-thiazole Analog 7n
- CHEMBL131577
- N-(2-chloro-6-methylphenyl)-2-[(cyclopropylcarbonyl)amino]-1,3-thiazole-5-carboxamide
|
BDBM136597
 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | - BDNF/NT-3 growth factors receptor
- High affinity nerve growth factor receptor
- NT-3 growth factor receptor
- Tyrosine kinase receptor A (TrkA)
- Tyrosine-protein kinase ABL1
| - US10005783, 14
- US10047097, 14
- US10774085, Example 14
- US8865698, 14
- US9676783, 14
|
BDBM13937
 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Prothrombin
- Trypsin
- Trypsin-1
- Urokinase-type plasminogen activator
| - 2-(2-HYDROXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE
- APC-1144
- {amino[2-(2-hydroxyphenyl)-1H-1,3-benzodiazol-5-yl]methylidene}azanium
|
BDBM140998
 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | - Rho-associated protein kinase 2
| - US10570123, Example 201
- US8916576, 201
|
BDBM14673
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - D-Aspartate Oxidase (DDO)
- D-amino-acid oxidase
- D-aspartate oxidase
- Proto-oncogene tyrosine-protein kinase Src (aa 145-252)
- Serine racemase
| - Fragment 3
- Malonic Acid
- propanedioic acid
|
BDBM149770
 | 2 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-secretase 1
- Potassium voltage-gated channel subfamily H member 2
| - US8975415, RP51a
- US8975415, RP51b
- US8975415, RP69
- US9242973, RP69
|
BDBM149773
 | 4 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-secretase 1
- Potassium voltage-gated channel subfamily H member 2
| - US8975415, RP108
- US8975415, RP53b
- US9242973, RP108
|
BDBM154573
 | 4 | 9 | 3 | 0 | 0 | 0 | 0 | 0 | - 3C-like proteinase (3CL-PRO)
- Dihydroorotase (PyrC)
- MERS-CoV papain-like protease (MERS-PLpro)
- NS3 serine protease (NS3)
- SARS Coronavirus Coronavirus Papain-Like Protease
- Tyrosine-protein kinase ABL1
| - 8-(trifluoromethyl)-9H-purin-6-amine (4)
- jm5b01461, Compound 188
|
BDBM155928
 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | - ATP-sensitive inward rectifier potassium channel 1
- ATP-sensitive inward rectifier potassium channel 10
- Cytochrome P450 2C8
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Inward rectifier potassium channel 13
- Inward rectifier potassium channel 2
- Inward rectifier potassium channel 4
- Potassium voltage-gated channel subfamily H member 2
- Renal Outer Medullary Potassium (ROMK)
- Sodium channel protein type 2 alpha subunit
- Sodium channel protein type 7 subunit alpha
| |
BDBM161920
 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | - Activin receptor type-1
- Activin receptor type-1B
- Activin receptor type-1B/Activin receptor-like kinase 4 (ALK-4)
- Activin receptor-like kinase 3 (ALK-3)
- Bone morphogenetic protein receptor type-1B (BMPR1B) aa 168-495
- Serine/threonine-protein kinase receptor R3
- Serine/threonine-protein kinase receptor R3 (ALK1)
- TGF-beta receptor type-1
| - US10017516, Compound 53
- US9682983, 52
- US9682983, 53
|
BDBM163888
 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| - US9062078, 167
- US9062078, 19
- US9475819, 19
- US9637496, 19
- US9695183, 19
|
BDBM163906
 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 2
| - US9062078, 166
- US9062078, 37
- US9475819, 37
- US9637496, 37
- US9695183, 37
|
BDBM163976
 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1 (OX1)
- Orexin receptor type 2
| - US9062078, 107
- US9062078, 173
- US9475819, 107
- US9637496, 107
- US9695183, 173
|
BDBM165523
 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | - Tyrosine-protein kinase BTK
| - US10604504, Example 172
- US9688629, 169
- US9688629, 170
- US9688629, 171
- US9688629, 172
- US9802915, Example 172
- US9920031, Example 172
|
BDBM16591
 | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | - 3-phosphoinositide dependent protein kinase-1
- Axin-1/Glycogen synthase kinase-3 beta
- Checkpoint Kinase (Chk2)
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-dependent kinase 1
- Cyclin-dependent kinase 5 regulatory subunit 1
- Mitogen-activated protein kinase 1
- RAC-alpha serine/threonine-protein kinase
- Serine/threonine-protein kinase CHK2
- Serine/threonine-protein kinase Chk1/2
- cAMP-dependent protein kinase (PKA)
| - (4Z)-4-(2-amino-5-oxo-3,5-dihydro-4H-imidazol-4-ylidene)-4,5,6,7-tetrahydropyrrolo[2,3-c]azepin-8(1H)-one
- 2-amino-5-[(4Z)-8-oxo-1H,4H,5H,6H,7H,8H-pyrrolo[2,3-c]azepin-4-ylidene]-4,5-dihydro-1H-imidazol-4-one
- B722657K110
- CHEMBL255465
- Debromohymenialdisine (DBH)
- Hymenialdisine, 8
- NSC607174
|
BDBM168281
 | 2 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | - MAP kinase-interacting serine/threonine-protein kinase 1
- MAP kinase-interacting serine/threonine-protein kinase 1/2
- MAP kinase-interacting serine/threonine-protein kinase 2
| - US9669031, 109 8-chloro-6-(pyrimidin-4-ylamino)spiro[2H-imidazo[1,5-a]pyridine-3,1′-cyclohexane]-1,5-dione hydrochloride (Cpd. No. 109)
|
BDBM168436
 | 0 | 7 | 0 | 9 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 3A
- Pteridine reductase 1
- Small conductance calcium-activated potassium channel protein 1 (KCa2.1)
- Small conductance calcium-activated potassium channel protein 2 (KCa2.2)
- Small conductance calcium-activated potassium channel protein 3 (KCa2.3)
- Sodium channel alpha subunit
- Sodium channel protein type 2 alpha subunit
- Sodium channel protein type 5 subunit alpha
- Voltage-gated potassium channel subunit Kv2.1 (Kv2.1)
- Voltage-gated sodium channel subunit alpha Nav1.3 (Nav1.3)
- Voltage-gated sodium channel subunit alpha Nav1.4 (Nav1.4)
| |
BDBM172423
 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Delta-type opioid receptor
- Kappa-type opioid receptor
- Mu-type opioid receptor
- Nociceptin receptor
- Opioid growth factor receptor-like protein 1
| - US9090618, ZA46
- US9090618, ZA54
- US9598411, Ref. No. ZA54
|
BDBM17277
 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Prothrombin
- Trypsin
| - (Z,Z)BABCH
- 4-{[(1Z,3Z)-3-[(4-carbamimidoylphenyl)methylidene]-2-oxocycloheptylidene]methyl}benzene-1-carboximidamide
- CHEMBL55035
|
BDBM173250
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 2
- US9096596, 2
- US9604982, Example 2
|
BDBM173258
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 10
- US9096596, 10
- US9604982, Example 10
|
BDBM173259
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 11
- US9096596, 11
- US9604982, Example 11
|
BDBM173262
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 14
- US9096596, 14
- US9604982, Example 14
|
BDBM173263
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 15
- US9096596, 15
- US9604982, Example 15
|
BDBM173266
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 18
- US9096596, 18
- US9604982, Example 18
|
BDBM173268
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 20
- US9096596, 20
- US9604982, Example 20
|
BDBM173296
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 34
- US9096596, 34
- US9604982, Example 34
|
BDBM173298
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 35
- US9096596, 35
- US9604982, Example 35
|
BDBM173301
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 37
- US9096596, 37
- US9604982, Example 37
|
BDBM173302
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 38
- US9096596, 38
- US9604982, Example 38
|
BDBM173304
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 39
- US9096596, 39
- US9604982, Example 39
|
BDBM173310
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 43
- US9096596, 43
- US9604982, Example 43
|
BDBM173371
 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 84
- US9096596, 84
- US9604982, Example 84
|
BDBM173376
 | 8 | 8 | 0 | 0 | 0 | 0 |
Search and Browse
